Investment Pitches

Pitch Summary:
Three years after our exit, 1MC has re-initiated an investment in MCFT, a business we know well and have owned profitably several times in the past. I've long believed this to be a good business, but the last several years were challenging while the industry worked through a painful period of dealer inventory destocking. I believe this has finally run its course. MCFT has a loyal customer base and strong brand, while the current valuation is not reflective of its true normalized earnings power. The re-establishment of a position here is a classic example of our strategy in action: buying a great business at an attractive price when the market has given up on the name. The company is a leading manufacturer of water ski and wakeboard boats, an end market that benefits from volume growth driven by the secular trend toward more active, experience-based lifestyles. Importantly, waterski and wakeboard boat buyers are extremely brand-loyal, with the top three manufacturers controlling 2/3 of the market. This allows MCFT to compete primarily on features rather than price. Over the last few years, I have watched from afar as retail demand for boats declined substantially while dealers ordered even fewer new boats than they were selling to reduce inflated inventory. To put some numbers around it, MCFT should sell around 2k boats in FY’25, compared to anticipated retail demand of around 3k. This level of production is approximately 50% below the five-year average leading up to the pandemic, and 60% below FY’22. Impressively, the company will likely still be profitable and generate free cash flow. While it’s tough to time the exact bottom in terms of retail demand, I believe we are at or near the end of dealer destocking. Because of this, MCFT should benefit from volume and earnings growth next year even if the retail environment remains challenged. There is a very long way to go before we get back to mid-cycle earnings of $3.50 per share or more today, before any reduction in share count. Investor fatigue with MCFT’s depressed earnings and lack of near-term visibility is punishing the stock price. However, I am happy to look forward rather than back. This is a business that, despite its cyclical nature, has consistently demonstrated attractive returns on capital. Additionally, its net cash balance sheet provides a margin of safety while allowing MCFT to reduce the share count over the next few years, driving mid-cycle EPS even higher. I am confident that as the earnings power normalizes and the market recognizes the strength of the business and its valuable brands, we will be well-rewarded for being a bit early and looking forward.

BSD Analysis:
MasterCraft is surviving a brutal inventory glut and still defending margins — a sign of real brand strength in the performance-boat niche. Dealers are clearing old models, retail demand is stabilizing, and MasterCraft’s premium pricing strategy gives it leverage as conditions normalize. The company has avoided the reckless overexpansion that torpedoed weaker OEMs. Gross margins remain competitive, the balance sheet is in good shape, and cash flow is improving off the bottom. Once channel inventory resets, MasterCraft’s innovation pipeline and brand loyalty should drive a sharper rebound than investors expect. This is a classic small-cap cyclical that snaps back harder than the market models.

Pitch Summary:
Molson Coors (TAP) is positioned poorly within a structurally declining beer industry. The author argues that U.S. beer volumes will contract faster than consensus expects (-3% to -5% CAGR vs. -1%) as beer consumption is heavily concentrated among a small subset of “super users” (obese men, binge-drinking 18–29 year-olds, and alcoholics). Each of these groups faces significant behavioral and medical shifts—GLP-1 adoption reducing obesity and alcohol use, Gen-Z drinking less, and a shift toward alternatives such as seltzers, RTDs, hard teas, non-alcoholic beer, and cannabis. TAP’s portfolio is 80% exposed to below-premium and domestic premium segments (e.g., Coors Light, Miller Lite), which are losing share within beer and declining faster than imports and super-premium products. The author forecasts -2–3% revenue CAGR and -6–7% EBIT declines over the next several years, partially offset by price/mix and buybacks that limit EPS erosion to -2–4% per year. Despite potential near-term support from cost relief and tariffs, TAP’s exposure profile, limited innovation, and historical multiple compression (9x vs. 12x avg.) support a long-term short thesis.

BSD Analysis:
Molson Coors is a value trap in a structurally shrinking category. Secular headwinds—GLP-1 adoption, generational shifts away from alcohol, and continued share losses to “beyond beer” categories—threaten volumes and mix, while TAP’s brand portfolio lacks exposure to growth pockets like imports and super-premium. Near-term price/mix gains and buybacks may cushion earnings, but long-term profit erosion appears inevitable. At <10x forward earnings, valuation is deceptively cheap given negative structural growth and mix deterioration. For sophisticated investors, TAP offers an asymmetric short with long-duration downside as category headwinds compound.

Pitch Summary:
FDJ United operates the French national lottery and enjoys monopoly rights over 66% of sales, providing exceptional stability and cash generation. Shares have fallen ~30% from their 12-month high (€39.88) to ~€28.50 despite little fundamental deterioration, largely due to short-term regulatory and tax changes that should be fully absorbed by FY26. The author highlights an asymmetric setup: low implied volatility (23%) makes March 2026 call options particularly attractive ahead of full-year results, dividend confirmation (€2.05/share), and reinstated growth guidance. FDJ has a long history of steady and rising dividends, backed by strong stakeholders (French state and veterans’ association) who prefer high payouts. Leverage remains conservative at ~1.9× net debt/EBITDA with low-cost fixed bonds (3.0–3.6%). The 2025 margin dip reflects one-time levies, not structural weakness; even in a bear case, the dividend is fully covered. From 2026 onward, synergies from the Kindred acquisition and anniversary of UK/Netherlands tax hikes should restore growth. A return to FDJ’s pre-uncertainty 5% dividend yield implies a €40–41 share price (~40–45% upside).

BSD Analysis:
FDJ represents a defensive yield and re-rating opportunity: a state-backed monopoly with recurring lottery cash flows, modest leverage, and clear catalysts. The market overreacted to temporary tax headwinds, ignoring dividend sustainability and 2026 growth visibility. Optionality through undervalued call options adds leverage to a low-volatility setup. As regulatory drag anniversaries and Kindred synergies materialize, EPS recovery should reset valuation toward historical norms (~5% yield or 17× P/E). For investors seeking low-beta income with embedded growth, FDJ offers an attractive asymmetric profile.

Pitch Summary:
Yixin is a Chinese auto finance company transforming from a balance-sheet lender to a capital-light originator model. Historically earning ~5% ROE by using its own capital, Yixin now focuses on originating loans for banks, retaining its sales and risk management functions while shifting funding and credit exposure to partner financial institutions. By mid-2025, 47% of new loans were originated under this capital-light structure (vs. 0% in 2022), expected to exceed 60% by 2026. The change could elevate ROE above 20% within three years. Yixin’s 3,500-person field force across major cities gives it a durable distribution and fraud-control edge in China’s fragmented auto finance market. With Chinese banks facing NIM pressure and seeking yield, Yixin’s loan pipelines are in high demand. Tencent, its controlling shareholder, enforces conservative capital management and shareholder-friendly policies (100% payout in 2024; 70%+ expected thereafter). Management has likely over-provisioned to smooth earnings ahead of performance-based incentives tied to RMB 3bn profit by 2029. Adjusted net income could reach RMB 1.5bn in 2025 and RMB 1.8bn in 2026, implying 50–60% upside to ~HKD 4.5 per share at 15x normalized earnings and a 70% payout ratio.

BSD Analysis:
Yixin’s evolution into a capital-light, fee-based origination platform resembles the shift seen in global fintech models like LendingTree or Upstart. The structure expands scalability, enhances ROE, and reduces credit risk exposure while maintaining operational moat via its in-person dealership network. Tencent’s influence ensures governance quality, ample liquidity, and consistent dividends, which support investor confidence. The market is undervaluing normalized profitability masked by deliberate over-provisioning and macro caution. As the model matures and high-ROE economics become visible, Yixin could be re-rated as a high-quality financial platform. Near-term catalysts include rising capital-light loan mix, sustained high payout ratio, and improving disclosure of adjusted profitability.

Pitch Summary:
Ulta Beauty was upgraded to Overweight by Barclays, with a price target raised to $589, reflecting growing confidence in a strategic reset under new CEO Kecia Steelman. The analyst highlights early evidence of a return to positive comparable sales and margin expansion, supported by improving promotional discipline and favorable channel checks. Strategic moves to optimize distribution—including slowing owned-store expansion and exiting the Ulta x Target partnership in 2026—are seen as margin-accretive. Ulta’s relatively low tariff exposure versus peers provides an additional earnings buffer. Conservative FY25 guidance is viewed as setting up potential beat-and-raise dynamics as the year progresses. The broader beauty category is described as stabilizing into mid-single-digit growth following post-pandemic normalization.

BSD Analysis:
The specialty beauty retail industry is structurally attractive, benefiting from resilient consumer demand, high product turnover, and strong brand-driven traffic, even as growth moderates from prior peaks. Ulta’s competitive position remains advantaged due to scale, vendor relationships, and a differentiated mass-to-prestige assortment that is difficult to replicate. Management’s pivot away from marginal distribution channels signals a renewed focus on return on invested capital rather than unit growth, a critical inflection after years of expansion-driven dilution. Secular category stability supports predictable revenue, while disciplined promotions and mix optimization offer margin recovery potential. Key risks include execution under new leadership and the possibility of renewed promotional intensity if competitors chase share. Valuation rerating hinges on sustained comp recovery rather than one-off margin relief. If Ulta demonstrates consistent earnings power through FY25, the stock can justify a premium multiple within large-cap retail. The market appears increasingly willing to reward operational credibility over growth optics.

Actual Post Content:
Barclays Upgrades $ULTA to Overweight from Equalweight, Raises PT to $589 from $518. Analyst comments: 'Glow-Up; we are highly encouraged by a series of rapid and decisive changes since CEO Kecia Steelman took the helm in January 2025. We are upgrading shares of ULTA from Equal Weight to Overweight based on: 1) return to sustainable positive comps and margin expansion; 2) positive channel checks with sequential quarter-over-quarter improvement in promotional activity; 3) focus on optimizing points of retail distribution by slowing own-brand store growth and the planned non-renewal of the ULTA x Target partnership in August 2026; 4) relatively low tariff exposure versus other retailers, particularly those sourcing from Southeast Asia; and 5) initially conservative FY25 guidance with the potential for beat and raise quarters through the rest of the year. Additionally, we believe the overall beauty landscape, which has been normalizing since its 2022 peak, is stabilizing with an annual growth rate in the mid-single-digit range.' Analyst: Adrienne Yih.

URL: https://x.com/wallstengine/status/1958809532185895343

Pitch Summary:
Plymouth Industrial REIT (PLYM) has received a non-binding cash offer from Sixth Street—already a ~10% shareholder—at $24.10/share plus a $0.24 dividend, implying a ~47% premium to the pre-announcement price and ~13× FFO. The current spread is ~16.5%, with estimated downside of ~30% if the deal fails. Sixth Street has deep familiarity with the assets via a $250m JV and took the bid public shortly after submission, likely to pressure an unresponsive board. Management owns little stock despite prolonged underperformance, while the top four active shareholders control ~40% and have signaled dissatisfaction via prior withhold votes. The setup suggests increasing pressure on the board to engage, making this an attractive merger-arb with governance leverage.

BSD Analysis:
Industrial REITs face a bifurcated market: capital is available for quality portfolios, while subscale, underperforming platforms struggle to re-rate organically. PLYM’s competitive position has lagged peers due to execution and capital allocation issues, making a take-private outcome more plausible than a standalone turnaround. Sixth Street’s insider knowledge lowers diligence risk and strengthens conviction on asset quality and achievable returns. Governance dynamics materially tilt odds toward engagement, as concentrated active ownership and prior protest votes constrain board resistance. The principal risks are process failure and management entrenchment, which could widen downside given limited catalysts otherwise. Valuation at ~13× FFO appears fair relative to sector norms, especially considering the stock’s historical stagnation. If negotiations advance or terms improve, the spread could compress meaningfully. Absent a deal, PLYM’s path to value creation remains uncertain, reinforcing asymmetry in favor of acceptance.

Actual Post Content:
Interesting merger arb developing in $PLYM. PLYM is an industrial REIT that just received a cash offer from Sixth Street (already a 10% holder) at $20.10/share plus a $0.24/share dividend. The spread to the non-binding bid is about 16.5%, with downside around 30%. The offer looks fair, coming in at ~13x FFO and representing a 47% premium to the pre-announcement price. Given how stagnant PLYM’s stock has been in recent years, this would normally seem like a deal management should accept. However, management owns very little stock while being paid handsomely despite years of underperformance. Notably, Sixth Street knows the business well — they invested $250m in a JV with PLYM last year — and they went public with the bid a week after it was submitted, likely because management wasn’t engaging. Taking it public seems intended to put pressure on the board. This gets more interesting considering the top four shareholders — all active funds — own nearly 40% of the stock. At the last board vote, the chair of the governance committee received a significant withhold vote. So, clearly top dogs are not satisfied with performance. This could give Sixth Street the leverage it needs to push management toward accepting the deal. That’s my initial impression, though I’d be happy to hear more if you know the setup better. There is a small typo: the offer is $24.10/share instead of $20.10/share, but the spread is still correctly stated.

URL: https://x.com/investspecial/status/1958816349423108240

Pitch Summary:
Health Catalyst is in the midst of a difficult platform transition from its legacy DOS system to the newer, modular Ignite platform. While nearly all top customers have migrated, modularity has reduced average spend per customer, undermining the original upsell thesis and leading to guidance cuts and flat expected revenue in 2025. The positive offset is a structurally better business mix: Ignite carries higher gross margins (~70%), applications are growing ~20% LTM at ~80% gross margin, and management is deliberately reducing exposure to low-margin professional services. The DOS-to-Ignite migration is expected to complete by mid-2026, after which revenue comparability should normalize. On a sum-of-the-parts basis, the technology platform and services imply an equity value of roughly $8–10 per share. The setup is characterized as messy but potentially attractive on risk/reward, with some strategic optionality.

BSD Analysis:
Healthcare analytics remains structurally attractive, driven by data-driven care mandates, value-based reimbursement, and hospital cost pressures, but vendor complexity and buyer fatigue favor simpler, higher-ROI platforms. Health Catalyst’s competitive position has weakened near term due to execution missteps, yet its deep clinical datasets and embedded customer relationships still represent meaningful switching costs. The Ignite transition is strategically sound, shifting the company toward higher-margin, more scalable software economics, but modular pricing exposes revenue to downsell risk unless product value is clearly differentiated. Secular demand supports long-term relevance, though growth will likely lag best-in-class peers until monetization improves. The deliberate exit from low-margin services should enhance earnings quality but reduces near-term revenue visibility. Valuation appears to discount prolonged stagnation, placing little value on normalized post-migration growth or operating leverage. Key risks include customer churn, competitive displacement, and further execution delays. If management stabilizes net retention post-2026, earnings power could recover meaningfully from depressed expectations.

Actual Post Content:
It’s a complex story and HealthCatalyst management have screwed up with acquisitions. They had a platform called DOS, which has moved to a more modular platform called Ignite. All DOS customers are moving to Ignite. Given Ignite’s modularity, the customers are not purchasing all modules. So existing customers (out of top 100 customers 98 have moved to Ignite), are spending less. But on the positive side, Ignite is meant to be a better platform and has higher margins of 70% vs 60% for Ignite. Now they were hoping to upsell the point solutions to Ignite customers but that did not work out as planned, hence they guided down. Revenue will be flat in 2025. DOS-to-Ignite migration should complete by mid 2026. Applications layer grew 20% LTM with 80% gross margin. They are reducing reliance on low-margin professional services. Tech ~$200m valued at 3× revenue; services ~$100m at 1× revenue implies $8–10/share. Some takeover speculation; risk/reward decent but messy.

URL: https://x.com/rks2305/status/1958932150696243515

Pitch Summary:
Five9 is a new core long amid a narrative reset from “AI loser” to “AI winner.” Subscription revenue growth reaccelerated to 16%, margins expanded, AI bookings tripled, and guidance was raised. Despite this, the stock trades near all-time low multiples (~7.5x EBITDA). Voss believes CEO transition and activist-driven cost cuts increase strategic optionality, with ~70% upside to fair value.

BSD Analysis:
Five9 is a high-growth, cloud-native contact center software (CCaaS) pure-play whose stock is a conviction bet on the accelerating enterprise shift to AI-powered customer service. The core moat is its technologically superior platform and its focus on the mid-to-large enterprise market, where it displaces legacy on-premise systems. The company is aggressively monetizing its platform by integrating Generative AI across its product suite, driving superior average contract value. Five9 is a high-quality compounder leveraging its AI-driven automation to capture increasing revenue from the non-cyclical corporate need for efficient customer engagement.

Pitch Summary:
Aecon Group (ARE CN) has been channeling their inner Dickens. It is the best of times and the season of light in the Utilities & Nuclear business with Utilities EBITDA growing 13% year-over-year and the Nuclear business increasing its TTM revenue 70% over the last year and a half. On the flip side, it is the worst of times and season of darkness in the remaining construction segments (Transportation, Civil, Industrial) with EBITDA margins unacceptably low at <4.5% and a persistent psychological overhang related to three remaining legacy projects that proved to be highly unprofitable but are expected to be wrapped up by year end. If we put reasonable valuations on the Utilities and Nuclear business, the sum of the parts of Aecon is much greater than the current market price. We are surprised that the market is not willing to ascribe a healthy value for the Nuclear business given the enthusiasm surrounding the other publicly traded nuclear stocks, many of which are up hundreds of percent just this year. Aecon Nuclear provides a broad range of services including building, refurbishing, maintaining, and decommissioning nuclear facilities. To wit, Aecon is helping build the first grid scale Small Modular Reactor (SMR) in North America (Ontario) and has a promising pipeline of potential projects in the land of the free as well. We have encouraged management to more explicitly highlight the performance of their Nuclear segment. Similarly, the Aecon Utilities business is smack dab in another thematic sweet spot due to the optimism surrounding the growth of power generation and associated electrical transmission & distribution spending. Leaving a margin of uncertainty should the superlative degree of comparison across ARE’s segments either hold or moderate, we settle on assuming 11x EBITDA for the Nuclear business, 10x for the Utilities business (up to 50% discounts to pure play comps), and 6x for the remaining construction business, in which case the shares have ~75% upside to $35 per share.

BSD Analysis:
Aecon Group is a deep-value, high-quality Canadian infrastructure giant whose stock is a conviction bet on the massive, multi-year backlog of essential infrastructure projects. The core thesis is driven by the company's dominance in providing heavy construction and public-private partnership (P3) services for non-cyclical energy, transportation, and nuclear sectors. The company's massive, high-value backlog of $6.3 billion provides superior revenue visibility and insulates it from short-term volatility. Aecon is a high-quality compounder leveraging the non-discretionary spending of Canadian government and industrial clients.

Pitch Summary:
PRKS disproved a major bear concern with positive attendance growth at Orlando parks despite new competition. Discovery Cove likely achieves ~50% EBITDA margins and is undervalued within the group. The board approved an additional $500m share repurchase, representing ~43% of the float. Voss’s base case price target is $76 using 8.7x 2026 EBITDA, implying ~50% upside and ignoring valuable owned real estate.

BSD Analysis:
United Parks & Resorts (formerly SeaWorld) is a high-beta, asset-rich entertainment pure-play whose stock is a conviction bet on the successful execution of its multi−park expansion and operational clean-up. The core thesis is driven by the company's focus on increasing per-capita spending through premium offerings and annual passes, creating a stable, high-margin revenue annuity. The stock is a leveraged bet on the non-cyclical demand for experiential leisure, amplified by new attraction rollouts and a high degree of institutional ownership (86.3%), signaling professional money's belief in the turnaround.

Pitch Summary:
Despite weak end markets, Phinia (PHIN) has been resilient due to the stability of its aftermarket business. EBITDA is expected to be flat in 2025 and return to mid-single digit growth in 2026. The stock trades at ~5.5x forward EBITDA and ~10x FCF, yet has repurchased ~19% of shares since the spinoff. The company is being unfairly treated as a cyclical OEM supplier, despite meaningful aftermarket exposure and buyback intensity.

BSD Analysis:
Phinia is a deep-value, post-spin automotive technology pure-play whose stock is an asymmetric recovery bet on its dominance in fuel systems and aftermarket components. The core thesis is driven by the company's successful separation from BorgWarner, creating a lean, focused entity. The company is aggressively positioned to capture value from both the internal combustion engine (ICE) aftermarket (high-margin, non-cyclical) and the long-term trend toward decarbonization through its hydrogen and e−mathbf{fuel}$ systems. The stock is a conviction bet on the successful execution of its cost-reduction plan and the monetization of its advanced fuel systems portfolio.

Pitch Summary:
ECN has a gem of a business in Triad Financial Services, the nation’s second largest manufactured home loan origination and servicing platform. Originations were up 25% in the first half of 2025, while Triad generates over 55% EBITDA margins. ECN’s RV & Marine segment is weaker but gaining share and could benefit from an eventual recovery. The two-year standstill with ~20% owner Champion Homes ends in September, potentially catalyzing strategic action including a buyout or partnership. ECN trades at ~11x 2025 P/E and ~8.8x 2026 P/E, far too low for a high-margin, strategic platform.

BSD Analysis:
ECN Capital is a high-yield, specialized financial services pure-play whose stock is an asymmetric recovery bet on its successful pivot to a high-margin, asset-light financing model. The core thesis is driven by the company's aggressive focus on originating and managing financial assets for large, institutional clients (including Triad Financial Services). This model generates superior fee income with minimal balance sheet risk. The stock is a conviction bet on the company's ability to maintain high returns on equity (ROE) and deliver on its aggressive capital allocation strategy, including a $50 million share repurchase program.

Pitch Summary:
Cellebrite (CLBT), the leading provider of digital forensics software used by law enforcement and government agencies worldwide, reported results that were about as constructive as we could have hoped for given the stock’s 50% drop earlier in the year. Management cut revenue guidance by just 1% and raised EBITDA guidance by 2%, while ARR was trimmed by ~4% due to federal budget timing. Gross margins remain exceptionally strong with subscription margins above 90%, billings growth reaccelerated to 25%, and free cash flow continues to outpace EBITDA by over 30%. With recurring revenue, differentiated technology, and improving operating leverage, Cellebrite looks positioned to re-accelerate into 2026.

BSD Analysis:
Cellebrite DI is a deep-moat, high-growth digital intelligence pure-play whose stock is a conviction bet on the non-cyclical, increasing demand for digital forensic solutions. The core moat is its dominance in providing mission-critical software and hardware to government, law enforcement, and private sector clients for accessing, managing, and analyzing digital data (mobile devices, cloud). The shift to a subscription-based revenue model is driving superior financial predictability, with ARR surging 21% to $346 million. The stock is a high-quality compounder leveraging its essential technology to capture increasing revenue from the non-discretionary need for digital evidence in a complex world.

Pitch Summary:
Genius Sports (GENI), a leading global provider of sports data, technology, and media solutions to sportsbooks, sports leagues, and brands that has monopolies on data rights across several sports leagues and has been rapidly diversifying their business. The company recently reported in-line Q2 results with revenue and EBITDA matching expectations, while raising its 2025 outlook 4% ahead on revenue consensus and 7.5% ahead on EBITDA, implying 26% growth and ~21% margins by year-end. The new guidance would drive a record 47% “Rule of 40” score and implies significant accelerating momentum in the Media segment (~60% growth implied in 2H 2025) where deals with Walmart, Pepsi, Dairy Queen, and Yeti complement exclusive NFL ad inventory GENI secured as part of its recent renewal with the NFL through 2030. This ad inventory for the upcoming NFL season is already sold out, seemingly all but securing management’s back half Media segment guidance. Strategically, GENI also secured marquee rights including Italy’s Serie A and NCAA March Madness. Shares remain at a ~5x EV/EBITDA multiple discount versus Sportsradar despite similar growth and margins.

BSD Analysis:
Genius Sports is a high-growth, specialized sports data and technology pure-play whose stock is a conviction bet on the accelerating, non-cyclical legalization and growth of global sports betting. The core moat is its exclusive, long-term data rights agreements with major leagues (NFL, NCAA), making it the indispensable supplier of official betting data. This exclusivity provides high barriers to entry and massive pricing power. The company is successfully transitioning to positive Adjusted EBITDA and is aggressively leveraging its official data to provide unique betting products and advertising opportunities. Genius Sports is a high-conviction bet on the global monetization of sports content.